Palisade Bio (PALI) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,817.00 |
| Dec 31, 2025 | 85,112.00 |
| Sep 30, 2025 | -29,141.00 |
| Jun 30, 2025 | -29,100.00 |
| Mar 31, 2025 | -9,483.00 |
| Dec 31, 2024 | -8,422.00 |
| Sep 30, 2024 | 482.00 |
| Jun 30, 2024 | 9,429.00 |
| Mar 31, 2024 | 2,625.00 |
| Dec 31, 2023 | 2,343.00 |
| Sep 30, 2023 | 2,804.00 |
| Jun 30, 2023 | -383.00 |
| Mar 31, 2023 | -128.00 |
| Dec 31, 2022 | -2,250.00 |
| Sep 30, 2022 | -5,711.00 |
| Jun 30, 2022 | -13,906.00 |
| Mar 31, 2022 | -39,182.00 |
| Dec 31, 2021 | -9,996.00 |
| Sep 30, 2021 | 31,651.00 |
| Jun 30, 2021 | 13,233.00 |
| Mar 31, 2021 | 24,065.00 |
| Dec 31, 2020 | -71,361.00 |
| Sep 30, 2020 | 6,799.00 |
| Jun 30, 2020 | 2,128.00 |
| Mar 31, 2020 | -3,995.00 |
| Dec 31, 2019 | -6,399.00 |
| Sep 30, 2019 | -11,712.00 |
| Jun 30, 2019 | -19,205.00 |
| Mar 31, 2019 | -9,243.00 |
| Dec 31, 2018 | -3,038.00 |
| Sep 30, 2018 | -944.00 |
| Jun 30, 2018 | 273.00 |
| Mar 31, 2018 | 1,240.00 |
| Dec 31, 2017 | 2,485.00 |
| Sep 30, 2017 | 5,289.00 |
| Jun 30, 2017 | 13,143.00 |
| Mar 31, 2017 | 25,850.00 |
| Dec 31, 2016 | 25,537.00 |
| Sep 30, 2016 | -34,284.00 |